111, Inc. (YI) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$3.14

From 52W high−62.59%

Volume7443.00

Market cap$27.58M

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataOct 19, 2026

Open

$3.14

From 52W high

−62.59%

Volume

7443.00

Market cap

$27.58M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−35.3x

P/E (TTM)

—

RSI (14)

43.0

MomentumView details →

1D Return

+0.16%

YTD Return

+24.22%

SummaryUpdated Jun 1, 2026

111, Inc. (NASDAQ:YI) is a Chinese healthcare technology company that operates an integrated online and offline platform connecting pharmaceutical companies, pharmacies, and consumers. Founded in 2010 and headquartered in Shanghai, the company went public on NASDAQ in September 2018. Originally known as New Peak Group, the company rebranded to 111, Inc. in April 2018. The company has evolved from a traditional pharmaceutical distributor to a digitally-driven healthcare platform that leverages artificial intelligence and data analytics to optimize the pharmaceutical supply chain in China.

Ask drillr about 111, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−35.3x

EV/Sales

0.1x

P/S (TTM)

0.0x

P/B (TTM)

−1.6x

ProfitabilityView details →

Gross Margin

5.73%

Net Margin

−0.91%

EBITDA Margin

−0.28%

ROE (TTM)

83.06%

ROA (TTM)

−5.31%

Asset Turnover

10.09x

GrowthView details →

Revenue YoY

−26.37%

EPS YoY

−39.25%

FCF YoY

—

Revenue CAGR 3Y

−3.32%

EPS CAGR 3Y

+1.33%

EBITDA YoY

—

MomentumView details →

1D Return

+0.16%

YTD Return

+24.22%

1Y Return

−27.73%

RSI (14)

43.0

vs 50D SMA

−7.57%

vs 200D SMA

−37.44%

Capital & dividendView details →

Debt/Equity

−2.46x

Current Ratio

1.07x

Quick Ratio

0.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.60

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

10.44B

Net Income (TTM)

−95.03M

Op. CF (TTM)

−35.20M

Next earningsNov 26, 2026 →

Latest newsMore news →

111, Inc. announced the establishment of a Special Committee comprising three independent directors.22d ago

111 Inc. received an unsolicited preliminary non-binding proposal dated September 16, 2026 from Dr. Gang Yu, its co-founder and co-chairman, and another party to acquire the company.33d ago

Similar companies

Pa Shun International Holdings Limited00574.HK AIxCrypto Holdings, Inc.AIXC PetMed Express, Inc.PETS LifeMD, Inc.LFMDP Sanai Health Industry Group Company Limited01889.HK Kyntra Bio, Inc.KYNB Find similar companies →

Latest newsMore news →

111, Inc. announced the establishment of a Special Committee comprising three independent directors.22d ago 111 Inc. received an unsolicited preliminary non-binding proposal dated September 16, 2026 from Dr. Gang Yu, its co-founder and co-chairman, and another party to acquire the company.33d ago 111, Inc. reported its unaudited financial results for the second quarter ended June 30, 2026, with net revenue of promotional products up 121% and gross profit up 120% year-over-year.33d ago